by Christine Craig, MS, RD, CDCES
Type 1 diabetes and celiac disease share a fascinating connection rooted in their autoimmune nature and shared genetic background.
In T1D, autoantibodies attack the insulin-producing beta cells of the pancreas, leading to insulin deficiency. In celiac disease, ingesting gluten triggers an immune response that damages the epithelial villi of the small intestine. Recent studies suggest that approximately 6% of individuals with T1D also have celiac disease, far higher than the prevalence of celiac disease in the general population, which is around 1%.
Shared Genetic Background
T1D and celiac disease have a shared genetic background, with 95% of individuals with type 1 and 99% of individuals with celiac having the presence of HLA class II genes as DQ2 and DQ8.1 While the presence of these DQ and other alleles increases the risk of developing T1D by 30–50%, most individuals with these genetic predispositions will never progress to develop either condition, this highlights the need for deeper insights into the factors predict that disease onset and progression.
Nobel Prize Awarded
In October 2024, the Nobel Prize in Physiology or Medicine was awarded to Victor Ambros and Gary Ruvkun for discovering microRNA and its role in post-transcriptional gene regulation.2 As we recall, messenger RNA is created by copying a gene sequence from DNA, carrying this genetic code to the ribosomes for protein synthesis- microRNAs up or down-regulate and “fine-tune” gene expression.2 MicroRNAs could be utilized to track what genes are expressed and in which cells. They could potentially be used as a tool for early detection and biomarkers of disease progression.
In T1D genetic risk combined with a triggering event leads to expression of autoantibodies. BreakthoughT1, previously JDRF,3 funded additional research on microRNA due to the potential to increase early prediction of T1D autoimmunity, provide additional biomarkers of Stage 1 and Stage 2 T1D progression, and for its potential to modulate the immune system by slowing down or ceasing autoimmune response. In celiac disease, tissue transglutaminase (TGA) and anti-endomysium autoantibody concentrations are used to screen individuals at risk of celiac disease, however these autoantibodies are often elevated when villous atrophy is already present. An article by Tan and colleagues4 reviewed 53 microRNAs as potential biomarkers of celiac disease, some were found more than a year before tissue transglutaminase (TGA) positivity, and some became normalized with initiation of a gluten-free diet.
microRNA enable earlier detection?
microRNA has the potential for early detection before the onset of intestinal damage. In both celiac disease and T1D, we currently use autoantibodies as predictors of disease development, but it is the biopsy of the villi4 or glucose levels that truly diagnose the stage of the disease. microRNAs may enable earlier detection of disease progression before significant damage occurs, revolutionizing current diagnostic and monitoring approaches.
AI to Develop Proteins to Treat Disease?
Another 2024 Nobel Prize awarded in Chemistry, also has implications for T1D and celiac research. David Baker, Demis Hassabis, and John Jumper received their prize for using artificial intelligence (AI) to develop computational protein design and predict protein structure.2 Their research led to the development of a new way to create proteins that have the potential to treat disease, make vaccines, and, important to T1D, develop new glucose-responsive insulins. These glucose-responsive insulins are currently in clinical trials and can activate in response to glucose needs after injection.5 In addition, their research led to the development of TAK-062, an investigational treatment aimed at improving gluten tolerance in individuals with celiac disease.6 TAK-062 holds promise as a therapeutic option to ease the burden of a strict gluten-free diet, which is currently the only treatment for celiac disease.
New Scientific Developments to Provide Future Benefits
Science continues to pave the way for new targeted therapies, and the 2024 Nobel Prizes highlight the breakthroughs which can benefit individuals with autoimmune conditions such as T1D and celiac diseases. The discoveries in protein design and microRNA regulation show promise for additional tools for prediction, early detection, and targeted therapies. Until then, nutrition therapy, diabetes education and a comprehensive team-based care approach remain the cornerstone of managing these complex conditions. If you’re interested in learning more check out all of the Nobel Prize winners here.
References
Join Coach Beverly and Team for two and a half days of knowledge-sharing, fun, and “aha” moments for our Virtual DiabetesEd Training Conference.
Attendees will leave this conference with new tools and a refreshed understanding of the latest advances in person-centered diabetes care. Our team highlights the ADA Standards of Care, medications, behavior change, technology, medical nutrition therapy, and more!
Our instructors co-teach the content to keep things fresh and lively.
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Becoming a Certified Diabetes Care and Education Specialist (CDCES) is an incredible achievement that not only demonstrates your expertise but also reflects your unwavering commitment to improving the lives of individuals with diabetes.
Whether you’re already on this path or just considering it, the fact that you are exploring the certification process shows your dedication to expanding your knowledge and enhancing the care you provide to individual with diabetes. Achieving this certification allows you to make an even greater impact in the field of diabetes care and education, empowering those with diabetes to live healthier, more fulfilling lives.
Below is an excerpt from the CBDCE Exam Handbook regarding what hours count towards this 1000-hour DSME requirement:
Tracking your activities and hours consistently is key, and these varied approaches can help you meet the requirements while making a positive impact in the community.
To log your hours we created the Diabetes Management Hours Tracker. The column “Remaining Hours Needed” is a formula that is tied to “Hours Completed” so be sure to only put numbers in the hour’s column so the formula automatically deducts those hours to get the remaining hours you need.
Meeting the 1,000-hour requirement for the Certified Diabetes Care and Education Specialist (CDCES) exam is achievable with a variety of approaches. The hours needed can include volunteer or paid hours. Below are some practical ways to accumulate hours if you are not able to accrue enough hours in your current work environment.
The road to becoming or renewing your CDCES certification may feel like a big task, but remember—you’re not alone in this journey. You’re part of a supportive community of healthcare professionals dedicated to improving diabetes care. By earning the required hours through work experience, and volunteer opportunities, you’ll build the skills and knowledge needed to pass the exam and make a lasting impact in the field of diabetes care.
You’ve already made the commitment to be the best diabetes care provider you can be. Keep going—you’re doing amazing things, and we’re here to support you along the way. If you need guidance or resources to get started, check out DiabetesEd.net for accredited courses, webinars, and study materials designed to help you succeed! We are excited to welcome you to this diabetes education community and hope you find this information helpful!
Get ready for the CDCES exam with our comprehensive online prep bundles, designed for healthcare professionals like you!
Choose the Perfect Bundle for You:
CDCES Boot Camp | Basic Exam Prep: Ideal for those looking for all-in-one access to Levels 1, 2, and 3, Toolkits, 30+ courses, 50 CEs/CPEUs, and 400+ practice questions.
CDCES Boot Camp | e-Deluxe Exam Prep: Includes everything in the Basic Bundle, plus the ADCES Certification Review Guide with 400+ additional practice questions.
Start your journey to CDCES success today!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
We are thrilled to announce the launch of the Diabetes Mentorship Program at Mercy Medical Center in Redding, designed to support and guide the next generation of diabetes educators. This unique opportunity is tailored for eight motivated mentees who are eager to gain hands-on experience in diabetes care, all while learning from Janelle Revnak, MS, RDN, CDCES, an experienced diabetes care and education specialist, with 10 years practicing as an RDN and 5 years as a CDCES. Janelle is passionate about sharing her expertise with the next generation of diabetes professionals. Her extensive background in both outpatient and inpatient diabetes education will ensure that mentees receive comprehensive training and valuable insights into the world of diabetes care.
Over the course of the program, mentees will attend monthly educational sessions led by Janelle, coupled with didactic learning sessions and job shadowing, providing an immersive experience in the inpatient setting. As part of our mentoring partnership, the trainees will also have access to our Diabetes Boot Camp series. Janelle decided to start this program after realizing that the need for diabetes education in her rural community was larger than what one person could realistically deliver. She reached out and identified colleagues in her hospital who were interested upping their diabetes knowledge and improving care.
“I alone cannot change the world, but I can cast a stone across the waters to create many ripples.” – Mother Teresa
As the number of people living with diabetes continues to rise, the demand for skilled diabetes educators is paramount. According to the latest CDC Data, the prevalence of diabetes has increased dramatically over the past decade, with more than 37 million Americans now living with diabetes—an increase of nearly 30% over the past 10 years. This growing population needs more than just medical care; they require specialized education and support to effectively manage their condition. Current diabetes care and education specialists (DCES) are uniquely positioned to assist in equipping future professionals with the knowledge and experience needed to meet the needs of this expanding patient population.
The mentorship program will be held once a month and is designed to create a balanced approach to learning. Mentees will dive deep into didactic topics, such as advanced diabetes management, behavior change strategies, and innovative approaches to diabetes care. In addition to classroom-style learning, they will have the opportunity to job-shadow Janelle, gaining firsthand experience in how diabetes education is applied in real-world inpatient clinical settings. This combination of theory and practice ensures mentees are well-equipped to make an impact in the field.
Participants will also have the chance to engage with a wide range of diabetes-related cases during their job shadowing. From inpatient diabetes clinical management to individualized patient education, they will develop a well-rounded understanding of the crucial role diabetes educators play in improving care outcomes while helping individuals feel emotionally supported through this challenging disease. This hands-on approach allows for active learning and real-time feedback, which is vital for shaping confident and competent DCES.
The mentorship program is not just about learning—it’s about making connections, fostering growth and building a community of passionate diabetes care professionals. We are excited to offer this incredible opportunity to those who are committed to advancing their skills and knowledge in diabetes education. Together, we can make a real difference in the lives of those living with diabetes. In the spirit of Mother Teresa, it is not one person alone that can impact the growing population affected by diabetes, but working together, we can achieve meaningful change.
If you have questions, you can reach Janelle at [email protected].
As part of our Bridge Program, Coach Beverly wants to support YOUR efforts to mentor a new generation of Diabetes Care and Education Specialists. If you are a mentor, we are offering significant discounts off of our Diabetes Boot Camp or Virtual 3 Day Program for groups of mentees who are practicing in underserved regions of our country. Please email us for more information at [email protected]
🎉 Join Our Virtual DiabetesEd Training Conference! 🎉
🗓️ Date:April 16th-18th, 2025
⏰ Time: 8:00am PST
Get ready for 2.5 days of engaging sessions on the latest in person-centered diabetes care, covering ADA Standards, medications, technology, and more! Learn from Diana Isaacs, Coach Beverly, and other experts.
💡 Can’t attend live? Access recordings, podcasts, and resources for 1 full year.
🎉 Special Offer: Register 3 or more and save $50 each!
Register now and take your diabetes expertise to the next level!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Given my seven-time experience taking the CDCES exam, I can say with complete conviction that being familiar with the American Diabetes Association (ADA) Standards of Care is one of the most important and essential strategies to prepare for exam success. More importantly, this evidence-based guidebook is crucial for providing the best clinical and person-centered care, with close attention to the Social Determinants of Health.
If you are taking the exam in January or February 2025 and you have already read the 2024 ADA Standards cover-to-cover, you are all set. It takes at least a year for the exam writers to include new questions culled from the ADA Standards. Having said that, if there are any critical new guidelines that impact clinical care, education, or treatment of diabetes, that content can be included in the exam that same year. From my review of the 2025 Standards, there are no critical new clinical guidelines that need immediate adoption into practice. One important caveat to consider: if you are relying on last year’s standards, make sure to read through the Summary of Revisions section included in the Standard of Care, so that you that latest information under your belt.
On the other hand, if you are taking the exam in 2025 and haven’t reviewed the ADA Standards in the past, I recommend a thorough review of the most recent ADA Standards. You can access the ADA Standards on our CDCES Coach App and the ADA Website at www.diabetes.org.
In case of emergency, there is a shorter version of the ADA Standards called the Abridged version for Primary Care Providers that highlights critical clinical content. The abridged version is usually released in February by the ADA. It can also be used as a quick review after you have read the document in full. Again, after successfully passing the exam seven times, my advice is to be familiar with the ADA Standards of Care in its entirety.
Below is an excerpt from the CBDCE Exam Handbook regarding what hours count towards this 1000-hour DSME requirement:
To help you keep track of your hours, we created the Diabetes Management Hours Tracker. The column “Remaining Hours Needed” is a formula that is tied to “Hours Completed” so be sure to only put numbers in the hour’s column so the formula automatically deducts those hours to get the remaining hours you need. Make sure you let your supervisor know you are tracking your hours, since they will need to attest and verify DSME hours completed.
Tracking your activities and hours consistently is key and this Hours Tracker excel sheet can help you tally your hours, while working toward your goal of becoming a CDCES.
Meeting the 1,000-hour requirement for the Certified Diabetes Care and Education Specialist (CDCES) exam is achievable with a variety of approaches. The hours needed can include volunteer or paid hours. Below are some practical ways to accumulate hours if you are not able to accrue enough hours in your current work environment.
As part of our Bridge Program, Coach Beverly wants to support YOUR efforts to mentor a new generation of Diabetes Care and Education Specialists. If you are a mentor, we are offering significant discounts off of our Diabetes Boot Camp or Virtual 3 Day Program for groups of mentees who are practicing in underserved regions of our country. Please email us for more information at [email protected]
This webinar provides a comprehensive breakdown of the ADA Standards of Care, focusing on essential content for clinical practice and exam success.
This webinar is designed for healthcare professionals aiming to deepen their understanding of the ADA Standards for improved practice or preparing for the BC-ADM or CDCES certification exams.
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
TZ is a 32-year-old female with type 2 diabetes and an A1C of 8.3% who takes metformin 1000mg twice daily and is on oral contraception. TZ is going to start tirzepitide 2.5mg weekly to help with weight loss and blood glucose management. According to the 2025 ADA Standards, what precaution would we recommend to TZ along with the initiation of tirzepitide?
According to the 2025 ADA Standards, what precaution would we recommend to TZ along with the initiation of tirzepitide?
This bundle is specifically designed for healthcare professionals who want to learn more about diabetes fundamentals for their clinical practice or for those who are studying for the Certified Diabetes Care and Education Specialist (CDCES) exam.
All hours earned count toward your CDCES Accreditation Information
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
For last week’s practice question, we quizzed participants on best meds to treat MASH. 64% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: In the 2025 ADA Standards, they have updated the term Non-Alcoholic Steatohepatitis (NASH) to Metabolic Associated Steatohepatitis (MASH). They also recommend pharmacologic agents along with lifestyle interventions to treat people with diabetes and MASH.
Which of the following are the recommended diabetes medications to treat MASH?
Answer Choices:
Answer 1 is incorrect. 14.93% chose this answer. “Vitamin E and SGLT-2.” While SGLT-2’s will help lower glucose levels and may result in some weight loss, the ADA does not recognize it as a treatment for steatosis. As far as Vitamin E, according to the ADA 2025 Standards, “it may be beneficial for the treatment of MASH in people without diabetes. However, in people with type 2 diabetes, vitamin E monotherapy was found to be ineffective in a small RCT, and it did not seem to enhance pioglitazone’s efficacy when used in combination, as reported in an earlier trial in this population.
Answer 2 is correct. 63.81% of you chose this answer. “Pioglitazone and/or GLP-1 RA / GIP.” GREAT JOB, this is the best answer. According to the ADA Standards In adults with type 2 diabetes with biopsy-proven MASH or those at high risk for liver fibrosis (based on noninvasive tests), pioglitazone, a GLP-1 RA, or a dual GIP and GLP-1 RA is preferred for glycemic management because of potential beneficial effects on MASH.
Answer 3 is incorrect. About 12.69% of respondents chose this. “Fish oil supplements and statin.” Part of this answer is correct. Based on the 2025 ADA Standards, “Statin therapy is safe in adults with type 2 diabetes and compensated cirrhosis from MASLD and should be initiated or continued for cardiovascular risk reduction as clinically indicated. In people with decompensated cirrhosis, statin therapy should be used with caution, and close monitoring is needed, given limited safety and efficacy data. However, the ADA does not recommend fish oil supplements to treat MASH.
Finally, Answer 4 is incorrect. 8.58% chose this answer. “Metformin and/or bolus insulin therapy.” Although metformin therapy and insulin are effective at addressing insulin resistance and lower glucose levels, they are not first line recommended agents to treat MASH.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
You are invited to join Coach Beverly for this FREE Webinar. And, if you want to have access to an additional 220+ sample practice online questions, you can purchase the complete Test Taking Toolkit.
During this webinar, Coach Beverly will help you transform your nervousness into focused energy that will help you succeed. She will provide test-taking tips based on her experience taking the certification exam six times.
All hours earned count toward your CDCES Accreditation Information
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
For last week’s practice question, we quizzed participants on 2025 ADA Standards & hyperglycemic crises. 43% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: What do the NEW 2025 ADA Standards Say?
According to the Newly Published 2025 Standards of Care, which of the following statements reflect the latest guidelines to treat hyperglycemic crises?
Answer Choices:
Answer 1 is correct. 43.04% chose this answer. “Administer low dose basal insulin analog in addition to intravenous insulin infusion to improve glucose management.” YES, great job, this is the best answer. According to ADA Standard 16 on Hospital Care, “Studies have reported that the administration of a low dose of basal insulin analog in addition to intravenous insulin infusion may prevent rebound hyperglycemia without increased risk of hypoglycemia.”
Answer 2 is incorrect. 19.59% of you chose this answer. “If serum pH is below 7.4, administer IV bicarb, along with a glucose infusion to resolve severe acidosis.” Since this pH is in the normal range, this person is not in ketoacidosis. According to ADA Standard 16 on Hospital Care, “Several studies have shown that the use of bicarbonate in people with DKA made no difference in the resolution of acidosis or time to discharge, and its use is generally not recommended.”
Answer 3 is incorrect. About 20.10% of respondents chose this. “To differentiate between DKA and HHS, the most important lab indicators are the anion gap and glucose levels.” According to the 2024 Consensus Statement, to differentiate between the two conditions, the most decisive lab indicators are beta hydroxybutyrate or urine ketones to verify insulin deficiency along with pH levels to verify acidosis and osmolality to determine hydration status in HHS.
Finally, Answer 4 is incorrect. 17.27% chose this answer. “Lactated Ringers is now the preferred intravenous solution for fluid resuscitation.” According to the 2024 Consensus Statement, Normal saline or Ringer’s lactate are both accepted IV rehydration solutions.
You are invited to register for our Hyperglycemic Crises – New criteria and treatment guidelines for DKA, Euglycemic DKA and HHS | 1.25 CE – Recorded and Ready for Viewing.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
This course, updated annually, is an essential review for anyone in the field of diabetes. Join Coach Beverly as she summarizes the annual updates to the American Diabetes Association’s (ADA) Standard of Medical Care in Diabetes & provides critical teaching points & content for healthcare professionals involved in diabetes care & education.
Objectives:
Learning Outcome: Participants will identify updates and articulate recommendations from the 2024 ADA Standards of Care that can be applied to their practice.
Target Audience: This course is a knowledge-based activity designed for individuals or groups of diabetes professionals, including RNs, RDs/RDNs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, and other healthcare providers interested in staying up to date on current practices of care for people with prediabetes, diabetes, and other related conditions. The practice areas for RDs/RDNs for CDR reporting are healthcare, preventative care, wellness, and, lifestyle along with, education and research.
Register above or simply visit our website.
For more information or any questions, please email [email protected].
All hours earned count toward your CDCES Accreditation Information
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
In the 2025 ADA Standards, they have updated the term Non-Alcoholic Steatohepatitis (NASH) to Metabolic Associated Steatohepatitis (MASH). They also recommend pharmacologic agents along with lifestyle interventions to treat people with diabetes and MASH.
Which of the following are the recommended diabetes medications to treat MASH?
Join us live on December 17, 2024, at 11:30 am PST for our Level 2 | Meds Management Update for Type 2 Diabetes
Title: Level 2 | Meds Management Update for Type 2 Diabetes | 1.5 CEs
This course is included in: Level 2 – Standards of Care. Purchase this course individually for $29 or enroll in the entire bundle and save 45% (discount already applied). Don’t worry if you can’t make it live, your registration gives you access to the recorded version for a full year.
Diabetes Education Services Online University Courses are an excellent way to study for your exam anytime and anywhere that is convenient for you. You will have immediate access to your courses for 1 year after your purchase date. Each online course includes a: video presentation, podcast, practice test, and additional resources.
All hours earned count toward your CDCES Accreditation Information
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
[yikes-mailchimp form="1"]
Diabetes Education Services offers education and training to diabetes educators in the areas of both Type 1 and Type 2 Diabetes for the novice to the established professional. Whether you are training to be a Certified Diabetes Care and Education Specialist (CDCES), practicing at an advanced level and interested in board certification, or a health care professional and/or Certified Diabetes Care and Education Specialist (CDCES) who needs continuing education hours to renew your license or CDCES, we have diabetes education information, resources and training; learning and teaching tools; and diabetes online courses available for continuing education (CE). Read our disclaimer for full disclosure.